Break for allergic asthma sufferers as ‘lifesaving’ drug subsidised – Herald Sun


Herald Sun

Break for allergic asthma sufferers as 'lifesaving' drug subsidised
Herald Sun
The Coalition will spend $5.4 million to make Omalizumab — an injectable medication used to treat severe asthma not controlled by corticosteroid inhalers — available to hundreds of patients across Australia. The drug is used to treat people who

and more »

View full post on asthma – Google News